|
|
 Previous Article | Table of Contents | Next Article 
Hematopoietic Remodeling in Interferon- -Deficient Mice
Infected With Mycobacteria
Peter J. Murray,
Richard A. Young, and
George Q. Daley
From the Whitehead Institute for Biomedical Research, Cambridge; and
the Department of Biology, Massachusetts Institute of Technology,
Cambridge, MA.
Control of intracellular bacterial infections requires
interferon- (IFN-) both for establishing a Th1 T-cell response
and for activating macrophages to kill the bacteria. Exposure of mice deficient in IFN- to mycobacterial infection produces an immune response characterized by a Th2 T-cell phenotype, florid bacterial growth, and death. We report here that IFN--deficient mice infected with mycobacteria also undergo a dramatic remodeling of the
hematopoietic system. Myeloid cell proliferation proceeds unchecked
throughout the course of mycobacterial infection, resulting in a
transition to extramedullary hematopoiesis. The splenic architecture of
infected IFN--deficient mice is completely effaced by expansion of
macrophages, granulocytes, and extramedullary hematopoietic tissue.
These features coincide with splenomegaly, an increase in splenic
myeloid colony-forming activity, and marked granulocytosis in the
peripheral blood. Systemic levels of cytokines are elevated,
particularly interleukin-6 (IL-6) and granulocyte colony-stimulating
factor (G-CSF). These results suggest that in addition to its central
role in cellular immunity, IFN- may be a key cytokine in coordinate
regulation of immune effector cells and myelopoiesis. This model should
be valuable for deciphering the cross-talk between the immune response
and hematopoiesis during bacterial infection and for improving our understanding of the mechanisms that control chronic infections.
Blood, Vol. 91 No. 8 (April 15), 1998:
pp. 2914-2924
© 1998 by The American Society of Hematology.
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati What's this?
This article has been cited by other articles:
|
|
|
|
 
D. Chiavolini, J. Alroy, C. A. King, P. Jorth, S. Weir, G. Madico, J. R. Murphy, and L. M. Wetzler
Identification of Immunologic and Pathologic Parameters of Death versus Survival in Respiratory Tularemia
Infect. Immun.,
February 1, 2008;
76(2):
486 - 496.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
I. Kotsianidis, J. D. Silk, E. Spanoudakis, S. Patterson, A. Almeida, R. R. Schmidt, C. Tsatalas, G. Bourikas, V. Cerundolo, I. A. G. Roberts, et al.
Regulation of hematopoiesis in vitro and in vivo by invariant NKT cells
Blood,
April 15, 2006;
107(8):
3138 - 3144.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
H. Kared, A. Masson, H. Adle-Biassette, J.-F. Bach, L. Chatenoud, and F. Zavala
Treatment With Granulocyte Colony-Stimulating Factor Prevents Diabetes in NOD Mice by Recruiting Plasmacytoid Dendritic Cells and Functional CD4+CD25+ Regulatory T-Cells
Diabetes,
January 1, 2005;
54(1):
78 - 84.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. J. Osborn, P. L. Ryan, N. Kirchhof, A. Panoskaltsis-Mortari, F. Mortari, and K.-S. R. S. Tudor
Overexpression of murine TSLP impairs lymphopoiesis and myelopoiesis
Blood,
February 1, 2004;
103(3):
843 - 851.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. G. Feng, C. M. Collazo-Custodio, M. Eckhaus, S. Hieny, Y. Belkaid, K. Elkins, D. Jankovic, G. A. Taylor, and A. Sher
Mice Deficient in LRG-47 Display Increased Susceptibility to Mycobacterial Infection Associated with the Induction of Lymphopenia
J. Immunol.,
January 15, 2004;
172(2):
1163 - 1168.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. A. Fulton, S. M. Reba, T. D. Martin, and W. H. Boom
Neutrophil-Mediated Mycobacteriocidal Immunity in the Lung during Mycobacterium bovis BCG Infection in C57BL/6 Mice
Infect. Immun.,
September 1, 2002;
70(9):
5322 - 5327.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
N. Perskvist, M. Long, O. Stendahl, and L. Zheng
Mycobacterium tuberculosis Promotes Apoptosis in Human Neutrophils by Activating Caspase-3 and Altering Expression of Bax/Bcl-xL Via an Oxygen-Dependent Pathway
J. Immunol.,
June 15, 2002;
168(12):
6358 - 6365.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Ehlers, J. Benini, H.-D. Held, C. Roeck, G. Alber, and S. Uhlig
{alpha}{beta} T Cell Receptor-positive Cells and Interferon-{gamma}, but not Inducible Nitric Oxide Synthase, Are Critical for Granuloma Necrosis in a Mouse Model of Mycobacteria-induced Pulmonary Immunopathology
J. Exp. Med.,
December 17, 2001;
194(12):
1847 - 1859.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Billiau and P. Matthys
Modes of action of Freund's adjuvants in experimental models of autoimmune diseases
J. Leukoc. Biol.,
December 1, 2001;
70(6):
849 - 860.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
L. H. Hogan, K. Macvilay, B. Barger, D. Co, I. Malkovska, G. Fennelly, and M. Sandor
Mycobacterium bovis Strain Bacillus Calmette-Guerin-Induced Liver Granulomas Contain a Diverse TCR Repertoire, but a Monoclonal T Cell Population Is Sufficient for Protective Granuloma Formation
J. Immunol.,
May 15, 2001;
166(10):
6367 - 6375.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
L. H. Hogan, W. Markofski, A. Bock, B. Barger, J. D. Morrissey, and M. Sandor
Mycobacterium bovis BCG-Induced Granuloma Formation Depends on Gamma Interferon and CD40 Ligand but Does Not Require CD28
Infect. Immun.,
April 1, 2001;
69(4):
2596 - 2603.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. Matthys, K. Vermeire, H. Heremans, and A. Billiau
The protective effect of IFN-{gamma} in experimental autoimmune diseases: a central role of mycobacterial adjuvant-induced myelopoiesis
J. Leukoc. Biol.,
October 1, 2000;
68(4):
447 - 454.
[Abstract]
[Full Text]
|
|
|
|
|
|
|
S. Ehlers and E. Richter
Gamma Interferon Is Essential for Clearing Mycobacterium genavense Infection
Infect. Immun.,
June 1, 2000;
68(6):
3720 - 3723.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. Kirman, Z. Zakaria, K. McCoy, B. Delahunt, and G. Le Gros
Role of Eosinophils in the Pathogenesis of Mycobacterium bovis BCG Infection in Gamma Interferon Receptor-Deficient Mice
Infect. Immun.,
May 1, 2000;
68(5):
2976 - 2978.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
E. H. Tran, E. N. Prince, and T. Owens
IFN-{gamma} Shapes Immune Invasion of the Central Nervous System Via Regulation of Chemokines
J. Immunol.,
March 1, 2000;
164(5):
2759 - 2768.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
N. Perskvist, L. Zheng, and O. Stendahl
Activation of Human Neutrophils by Mycobacterium tuberculosis H37Ra Involves Phospholipase C{gamma}2, Shc Adapter Protein, and p38 Mitogen-Activated Protein Kinase
J. Immunol.,
January 15, 2000;
164(2):
959 - 965.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. Matthys, K. Vermeire, T. Mitera, H. Heremans, S. Huang, D. Schols, C. De Wolf-Peeters, and A. Billiau
Enhanced Autoimmune Arthritis in IFN-{gamma} Receptor-Deficient Mice Is Conditioned by Mycobacteria in Freund's Adjuvant and by Increased Expansion of Mac-1+ Myeloid Cells
J. Immunol.,
September 15, 1999;
163(6):
3503 - 3510.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. J. Murray and R. A. Young
Increased Antimycobacterial Immunity in Interleukin-10-Deficient Mice
Infect. Immun.,
June 1, 1999;
67(6):
3087 - 3095.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
